Goldman Sachs Group Inc Akoya Biosciences, Inc. Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 13,326 shares of AKYA stock, worth $37,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,326
Previous 12,333
8.05%
Holding current value
$37,579
Previous $57,000
45.61%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AKYA
# of Institutions
60Shares Held
11.8MCall Options Held
67.9KPut Options Held
0-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$13.2 Million10.69% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.46MShares$4.13 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA562KShares$1.59 Million0.0% of portfolio
-
State Street Corp Boston, MA435KShares$1.23 Million0.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $107M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...